Effects of a high-protein diet on regulation of phosphorus homeostasis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages 1207-1213

  Kremsdorf, Robin A ^a,e   Hoofnagle, Andrew N ^b   Kratz, Mario ^a,b,c   Weigle, David S ^a   Callahan, Holly S ^b   Purnell, Jonathan Q ^d   Horgan, Angela M ^d   De Boer, Ian H ^a,b   Kestenbaum, Bryan R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; DAIRY PRODUCT; DIETARY INTAKE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; MACRONUTRIENT; MINERAL METABOLISM; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; PHOSPHATE METABOLISM; PHOSPHORUS HOMEOSTASIS; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN METABOLISM; PROTEIN RESTRICTION; VITAMIN BLOOD LEVEL;

24,25-DIHYDROXYVITAMIN D 3; ADULT; CALCIUM; CIRCADIAN RHYTHM; CREATININE; DIET, FAT-RESTRICTED; DIET, REDUCING; DIETARY PROTEINS; FEMALE; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; REFERENCE VALUES; VITAMIN D;

EID: 84874915228     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2910     Document Type: Article

References (29)

1. Hu FB, Stampfer MJ, Manson JE, et al. Dietary protein and risk of ischemic heart disease in women. Am J Clin Nutr. 1999;70:221-227. (Pubitemid 29347567)
2. Larsen TM, Dalskov SM, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010;363:2102-2113.
3. Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297: 969-977. (Pubitemid 46376751)
4. Due A, Toubro S, Skov AR, Astrup A. Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomised 1-year trial. Int J Obes Relat Metab Disord. 2004;28:1283-1290. (Pubitemid 39389586)
5. Weigle DS, Breen PA, Matthys CC, et al. Ahigh-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 2005;82:41-48. (Pubitemid 41716375)
6. Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. Am J Clin Nutr. 2008;87:1558S-1561S. (Pubitemid 351679810)
7. Dhingra R, Gona P, Benjamin EJ, et al. Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail. 2010;12: 812-818.
8. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879-885. (Pubitemid 46762749)
9. Isakova T, Xie H, Yang W, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305:2432-2439.
10. Parker BD, Schurgers LJ, Brandenburg VM, et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med. 2010;152:640-648.
11. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340-1349. (Pubitemid 351930842)
12. Kendrick J, Cheung AK, Kaufman JS, et al. Associations of plasma 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis. 2012;60:567-575.
13. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21: 1187-1196. (Pubitemid 44128331)
14. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006;91:3144-3149. (Pubitemid 44271770)
15. Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011;6:383-389.
16. Levey AS, Stevens LA, Schmid CH, et al. Anew equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
17. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112:2627-2633. (Pubitemid 41532599)
18. Linefsky JP, O'Brien KD, Katz R, et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the Cardiovascular Health Study. J Am Coll Cardiol. 2011;58:291-297.
19. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397-404.
20. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:E10-E17.
21. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-238. (Pubitemid 34787360)
22. Liu LC, Voors AA, van Veldhuisen DJ, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011;13:619-625.
23. Ix JH, Katz R, Kestenbaum BR, et al. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in communityliving individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol. 2012;60:200-207.
24. Di Iorio B, Di Micco L, Torraca S, et al. Acute effects of very-lowprotein diet on FGF23 levels: a randomized study. Clin J Am Soc Nephrol. 2012;7:581-587.
25. Sigrist M, Tang M, Beaulieu M, et al. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant. 2013;28:161-169.
26. Skov AR, Toubro S, Bulow J, Krabbe K, Parving HH, Astrup A. Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord. 1999;23:1170-1177.
27. Carpenter TO, Insogna KL, Zhang JH, et al. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab. 2010;95:E352-E357.
28. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief. 2011;59:1-8.
29. Mirza MA, Alsio J, Hammarstedt A, et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol. 2011;31:219-227.